About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [987 citations: 1–100 of 936 articles]

Articles published in Advances in Hematology have been cited 987 times. The following is a list of the 936 articles that have cited the articles published in Advances in Hematology.

  • Sae Rin Jean, David V. Tulumello, Simon P. Wisnovsky, Eric K. Lei, Mark P Pereira, and Shana O. Kelley, “Molecular Vehicles for Mitochondrial Chemical Biology and Drug Delivery,” ACS Chemical Biology, pp. 140112103555006, 2014. View at Publisher · View at Google Scholar
  • Keith Eagen, Zhuyan Guo, Samuel Chackalamannil, Yan Xia, Hsingan Tsai, William J. Greenlee, Ho-Sam Ahn, Stan Kurowski, George Boykow, Yunsheng Hsieh, and Madhu Chintala, “Himbacine-Derived Thrombin Receptor Antagonists: C-7-Spirocyclic Analogues of Vorapaxar,” Acs Medicinal Chemistry Letters, vol. 5, no. 5, pp. 561–565, 2014. View at Publisher · View at Google Scholar
  • Vinod Pullarkat, “Iron Toxicity in Hematopoietic Stem Cell Transplantation: Strike while the Iron Is Labile,” Acta Haematologica, vol. 131, no. 4, pp. 220–221, 2014. View at Publisher · View at Google Scholar
  • Jens Langhoff-Roos, Lone Krebs, Kari Klungsøyr, Ragnheidur I. Bjarnadottir, Karin Källén, Anna-Maija Tapper, Maija Jakobsson, Per E. Børdahl, Pelle G. Lindqvist, Karin Gottvall, Lotte Berdiin Colmorn, and Mika Gissler, “The Nordic medical birth registers - a potential goldmine for clinical research,” Acta Obstetricia et Gynecologica Scandinavica, vol. 93, no. 2, pp. 132–137, 2014. View at Publisher · View at Google Scholar
  • Christoph Giese, and Uwe Marx, “Human immunity in vitro – solving immunogenicity and more,” Advanced Drug Delivery Reviews, 2014. View at Publisher · View at Google Scholar
  • Emma Conway O’Brien, Steven Prideaux, and Timothy Chevassut, “The Epigenetic Landscape of Acute Myeloid Leukemia,” Advances in Hematology, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • David M. Aboulafia, and Andrew Zloza, “Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges,” Aids, vol. 28, no. 4, pp. 453–465, 2014. View at Publisher · View at Google Scholar
  • Andrew W. Y. Shih, Andrew McFarlane, and Madeleine Verhovsek, “Haptoglobin testing in hemolysis: Measurement and interpretation,” American Journal of Hematology, vol. 89, no. 4, pp. 443–447, 2014. View at Publisher · View at Google Scholar
  • Taxiarchis V. Kourelis, Shaji K. Kumar, Geetika Srivastava, Morie A. Gertz, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Steven R. Zeldenrust, Nelson Leung, Robert A. Kyle, Stephen J. Russell, David Dingli, John A. Lust, Yi Lin, Prashant Kapoor, Ronald Go, S. Vincent Rajkumar, and Angela Dispenzieri, “Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy,” American Journal of Hematology, 2014. View at Publisher · View at Google Scholar
  • Chindu Govindaraj, Mutsa Madondo, Ying Ying Kong, Peter Tan, Andrew Wei, and Magdalena Plebanski, “Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients,” American Journal of Hematology, 2014. View at Publisher · View at Google Scholar
  • Ye Zeng, Roger H. Adamson, Fitz-Roy E. Curry, and John M. Tarbell, “Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 306, no. 3, pp. H363–H372, 2014. View at Publisher · View at Google Scholar
  • C. Staikou, E. Stavroulakis, and I. Karmaniolou, “A narrative review of peri-operative management of patients with thalassaemia,” Anaesthesia, 2014. View at Publisher · View at Google Scholar
  • Unkyung Shin, David E. Williams, Dima Kozakov, David R. Hall, Dmitri Beglov, Sandor Vajda, Raymond J. Andersen, and Jerry Pelletier, “Stimulators of translation identified during a small molecule screening campaign,” Analytical Biochemistry, vol. 447, pp. 6–14, 2014. View at Publisher · View at Google Scholar
  • M. A. Pinan, M. T. Ardanaz, J. M. Guinea, and J. C. Garcia-Ruiz, “Myeloid sarcoma preceding an acute promyelocytic leukaemia with neuromeningeal infiltration,” Annals of Hematology, vol. 93, no. 2, pp. 339–340, 2014. View at Publisher · View at Google Scholar
  • Nikolai Schuelper, Antonius Flohr, Lorenz Trümper, and Gerald G. Wulf, “Osteolytic lesions in patients with relapse of diffuse large B-cell lymphoma treated with lenalidomide,” Annals of Hematology, 2014. View at Publisher · View at Google Scholar
  • Francesco Gaudio, Pasquale Pedote, Annunziata Ferrante, Tommasina Perrone, Giuseppe Ingravallo, Amato Antonio Stabile Ianora, Giuseppe Angelelli, and Giorgina Specchia, “CT-guided needle biopsy performed with modified coaxial technique in patients with refractory or recurrent lymphomas,” Annals of Hematology, vol. 93, no. 9, pp. 1559–1564, 2014. View at Publisher · View at Google Scholar
  • Paul A. Sigala, and Daniel E. Goldberg, “ The Peculiarities and Paradoxes of Plasmodium Heme Metabolism ,” Annual Review of Microbiology, vol. 68, no. 1, pp. 259–278, 2014. View at Publisher · View at Google Scholar
  • Donatella Pietraforte, Rosa Vona, Alessandra Marchesi, Isabella Tarissi de Jacobis, Alberto Villani, Domenico Del Principe, and Elisabetta Straface, “Redox control of platelet functions in physiology and pathophysiology,” Antioxidants & Redox Signaling, pp. 140305115422008, 2014. View at Publisher · View at Google Scholar
  • Fucun Liu, Xiaobing Chu, Jiefeng Huang, Kun Tian, Jiang Hua, and Peijian Tong, “Administration of enoxaparin 24 h after total knee arthroplasty: safer for bleeding and equally effective for deep venous thrombosis prevention,” Archives of Orthopaedic and Trauma Surgery, 2014. View at Publisher · View at Google Scholar
  • Walid Zaher, Linda Harkness, Abbas Jafari, and Moustapha Kassem, “An update of human mesenchymal stem cell biology and their clinical uses,” Archives of Toxicology, vol. 88, no. 5, pp. 1069–1082, 2014. View at Publisher · View at Google Scholar
  • Laura Iordache, Odile Launay, Olivier Bouchaud, Vincent Jeantils, Cécile Goujard, Francois Boue, Patrice Cacoub, Thomas Hanslik, Alfred Mahr, Olivier Lambotte, and Olivier Fain, “Autoimmune diseases in HIV-infected patients: 52 cases and literature review,” Autoimmunity Reviews, 2014. View at Publisher · View at Google Scholar
  • Rohola Hosseini, Gerda EM Lamers, Zlatan Hodzic, Annemarie H Meijer, Marcel JM Schaaf, and Herman P Spaink, “Correlative light and electron microscopy imaging of autophagy in a zebrafish infection model,” Autophagy, vol. 10, no. 10, pp. 90–89, 2014. View at Publisher · View at Google Scholar
  • Chezi Ganzel, and Dan Douer, “Extramedullary Disease in APL: A Real Phenomenon to Contend With or Not?,” Best Practice & Research Clinical Haematology, 2014. View at Publisher · View at Google Scholar
  • Jessica A. Beach, Laura J. Nary, Rebeka Hovanessian, and Rheem D. Medh, “Correlation of glucocorticoid-mediated E4BP4 upregulation with altered expression of pro- and anti-apoptotic genes in CEM human lymphoblastic leukemia cells,” Biochemical and Biophysical Research Communications, vol. 451, no. 3, pp. 382–388, 2014. View at Publisher · View at Google Scholar
  • Georgina Galicia, “Plasmacytoid dendritic cells and autoimmune inflammation,” Biological Chemistry, vol. 395, no. 3, pp. 335–346, 2014. View at Publisher · View at Google Scholar
  • Massimo Martino, Mauro Montanari, Felicetto Ferrara, Fabio Ciceri, Ilaria Scortechini, Salvatore Palmieri, Sarah Marktel, Michele Cimminiello, Giuseppe Messina, Giuseppe Irrera, Massimo Offidani, Giuseppe Console, Luca Castagna, Giuseppe Milone, Benedetto Bruno, Giovanni Tripepi, Roberto Massimo Lemoli, and Attilio Olivieri, “Very Low Rate of Readmission after an Early Discharge Outpatient Model for Autografting in Multiple Myeloma Patients: An Italian Multicenter Retrospective Study,” Biology of Blood and Marrow Transplantation, 2014. View at Publisher · View at Google Scholar
  • Erin Gatza, Thomas Braun, John E. Levine, James L.M. Ferrara, Shuang Zhao, Tianyi Wang, Lawrence Chang, Andrew Harris, Attaphol Pawarode, Carrie Kitko, John M. Magenau, Gregory A. Yanik, Daniel R. Couriel, Steven Goldstein, James Connelly, Pavan Reddy, Sophie Paczesny, and Sung Won Choi, “Etanercept plus Topical Corticosteroids as Initial Therapy for Grade One Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation,” Biology of Blood and Marrow Transplantation, 2014. View at Publisher · View at Google Scholar
  • Ke Zhao, Rui Lou, Fen Huang, Yanwen Peng, Zujun Jiang, Ke Huang, Xiuli Wu, Yu Zhang, Zhiping Fan, Hongsheng Zhou, Can Liu, Yang Xiao, Jing Sun, Yangqiu Li, Peng Xiang, and Qifa Liu, “Immunomodulation Effects of Mesenchymal Stromal Cells on Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation,” Biology of Blood and Marrow Transplantation, 2014. View at Publisher · View at Google Scholar
  • Marie-Christine Kyrtsonis, Katerina Sarris, Efstathios Koulieris, Dimitrios Maltezas, Eftychia Nikolaou, Maria K. Angelopoulou, Vassiliki Bartzis, Tatiana Tzenou, Maria Dimou, Mariana P. Siakandaris, Nora A. Viniou, Sotirios Sachanas, Christina Kalpadakis, Petros P. Sfikakis, Gerassimos A. Pangalis, and Panayiotis Panayiotidis, “Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia,” BioMed Research International, vol. 2014, pp. 1–5, 2014. View at Publisher · View at Google Scholar
  • Min Wang, Na He, Tian Tian, Lu Liu, Shuang Yu, and Daoxin Ma, “Mutation Analysis of JAK2V617F, FLT3-ITD, NPM1, and DNMT3A in Chinese Patients with Myeloproliferative Neoplasms,” BioMed Research International, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Jae Heon Kim, Hong Jun Lee, and Yun Seob Song, “Stem Cell Based Gene Therapy in Prostate Cancer,” BioMed Research International, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Rosário Pinto-Leite, Regina Arantes-Rodrigues, Rita Ferreira, Carlos Palmeira, Paula A. Oliveira, and Lúcio Santos, “Treatment of muscle invasive urinary bladders tumors: A potential role of the mTOR inhibitors,” Biomedicine & Aging Pathology, 2014. View at Publisher · View at Google Scholar
  • P. Mabeta, “Inhibition of phosphoinositide 3-kinase is associated with reduced angiogenesis and an altered expression of angiogenic markers in endothelioma cells,” Biomedicine & Pharmacotherapy, 2014. View at Publisher · View at Google Scholar
  • Brian Thabile Flepisi, Annemarie Giesen, Patrick Bouic, Gerhard Sissolak, and Bernd Rosenkranz, “Drug–drug interactions in HIV positive cancer patients,” Biomedicine & Pharmacotherapy, 2014. View at Publisher · View at Google Scholar
  • Shruti Setia, Bimla Nehru, and Sankar Nath Sanyal, “The PI3K/Akt pathway in colitis associated colon cancer and its chemoprevention with celecoxib, a Cox-2 selective inhibitor,” Biomedicine & Pharmacotherapy, 2014. View at Publisher · View at Google Scholar
  • Olivia Crociani, Andrea Becchetti, Duccio Fanelli, and Annarosa Arcangeli, “Adhesion-Mediated Signalling in Cancer: Recent Advances and Mathematical Modelling,” Biophysical Reviews and Letters, vol. 09, no. 03, pp. 285–300, 2014. View at Publisher · View at Google Scholar
  • Jianfeng Guo, Mary R. Cahill, Sharon L. McKenna, and Caitriona M. O’Driscoll, “Biomimetic nanoparticles for siRNA delivery in the treatment of leukaemia,” Biotechnology Advances, 2014. View at Publisher · View at Google Scholar
  • S. Adamia, M. Bar-Natan, B. Haibe-Kains, P. M. Pilarski, C. Bach, S. Pevzner, T. Calimeri, H. Avet-Loiseau, L. Lode, S. Verselis, E. A. Fox, I. Galinsky, S. Mathews, I. Dagogo-Jack, M. Wadleigh, D. P. Steensma, G. Motyckova, D. J. Deangelo, J. Quackenbush, D. G. Tenen, R. M. Stone, and J. D. Griffin, “NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML,” Blood, vol. 123, no. 18, pp. 2816–2825, 2014. View at Publisher · View at Google Scholar
  • G. Franco, C. Guarnotta, B. Frossi, P. P. Piccaluga, E. Boveri, A. Gulino, F. Fuligni, A. Rigoni, R. Porcasi, S. Buffa, E. Betto, A. M. Florena, V. Franco, E. Iannitto, L. Arcaini, S. A. Pileri, C. Pucillo, M. P. Colombo, S. Sangaletti, and C. Tripodo, “Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma,” Blood, vol. 123, no. 12, pp. 1836–1849, 2014. View at Publisher · View at Google Scholar
  • Jane F. Apperley, “How I treat leukemia during pregnancy,” Blood, vol. 123, no. 7, pp. 974–984, 2014. View at Publisher · View at Google Scholar
  • Steven T. Rosen, Joan Guitart, Madeleine Duvic, Youn H. Kim, Stephen W. Dusza, and Timothy M. Kuzel, “Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sezary syndrome,” Blood, vol. 123, no. 8, pp. 1159–1166, 2014. View at Publisher · View at Google Scholar
  • Silvio Antoniak, “Multiple roles of the coagulation protease cascade during virus infection,” Blood, vol. 123, no. 17, pp. 2605–2613, 2014. View at Publisher · View at Google Scholar
  • Erica Bresciani, Blake Carrington, Stephen Wincovitch, MaryPat Jones, Aniket V. Gore, Brant M. Weinstein, Raman Sood, and P. Paul Liu, “CBF beta and RUNX1 are required at 2 different steps during the development of hematopoietic stem cells in zebrafish,” Blood, vol. 124, no. 1, pp. 70–78, 2014. View at Publisher · View at Google Scholar
  • Silvia Spoerl, Nimitha R. Mathew, Michael Bscheider, Annette Schmitt-Graeff, Sophia Chen, Tony Mueller, Mareike Verbeek, Julius Fischer, Vera Otten, Martina Schmickl, Kristina Maas-Bauer, Juergen Finke, Christian Peschel, Justus Duyster, Hendrik Poeck, Robert Zeiser, and Nikolas von Bubnoff, “Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease,” Blood, vol. 123, no. 24, pp. 3832–3842, 2014. View at Publisher · View at Google Scholar
  • S. G. Holtan, M. Pasquini, and D. J. Weisdorf, “Acute graft-versus-host disease: a bench-to-bedside update,” Blood, vol. 124, no. 3, pp. 363–373, 2014. View at Publisher · View at Google Scholar
  • Paolo Arosio, “New signaling pathways for hepcidin regulation,” Blood, vol. 123, no. 10, pp. 1433–1434, 2014. View at Publisher · View at Google Scholar
  • Albertine E. Donker, Reinier A. P. Raymakers, L. Thom Vlasveld, Teus van Barneveld, Rieneke Terink, Natasja Dors, Paul P. T. Brons, Nine V. A. M. Knoers, and Dorine W. Swinkels, “Practice guidelines for the diagnosis and management of microcytic anemias due to genetic disorders of iron metabolism or heme synthesis,” Blood, vol. 123, no. 25, pp. 3873–3886, 2014. View at Publisher · View at Google Scholar
  • V. Brousse, and W. El Nemer, “Toward unraveling heme regulation,” Blood, vol. 123, no. 14, pp. 2134–2135, 2014. View at Publisher · View at Google Scholar
  • Yang Liu, Colin A. Kretz, Morgan L. Maeder, Catherine E. Richter, Philip Tsao, Andy H. Vo, Michael C. Huarng, Thomas Rode, Zhilian Hu, Rohit Mehra, Steven T. Olson, J. Keith Joung, and Jordan A. Shavit, “Targeted mutagenesis of zebrafish antithrombin III triggers disseminated intravascular coagulation and thrombosis, revealing insight into function,” Blood, vol. 124, no. 1, pp. 142–150, 2014. View at Publisher · View at Google Scholar
  • N. Shenoy, N. Vallumsetla, E. Rachmilewitz, A. Verma, and Y. Ginzburg, “Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome,” Blood, vol. 124, no. 6, pp. 873–881, 2014. View at Publisher · View at Google Scholar
  • Xiaoyan Jiang, “Distinguishing CML LSCs from HSCs using CD26,” Blood, vol. 123, no. 25, pp. 3851–3852, 2014. View at Publisher · View at Google Scholar
  • Doaa El Ghannam, Mona M. Taalab, Hayam F. Ghazy, and Asmaa F. Eneen, “DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome,” Blood Cells Molecules and Diseases, vol. 53, no. 1-2, pp. 61–66, 2014. View at Publisher · View at Google Scholar
  • Carolyn Glass, Michael Wilson, Ruby Gonzalez, Yi Zhang, and Archibald S. Perkins, “The role of EVI1 in myeloid malignancies,” Blood Cells, Molecules, and Diseases, vol. 53, no. 1-2, pp. 67–76, 2014. View at Publisher · View at Google Scholar
  • Lamia Ibrahem, Rabab Mahfouz, Loie Elhelw, Eman M Abdsalam, and Rehan Soliman, “Prognostic significance of DNMT3A mutations in patients with acute myeloid leukemia,” Blood Cells, Molecules, and Diseases, 2014. View at Publisher · View at Google Scholar
  • George S. Laszlo, Elihu H. Estey, and Roland B. Walter, “The Past and Future of CD33 as Therapeutic Target in Acute Myeloid Leukemia,” Blood Reviews, 2014. View at Publisher · View at Google Scholar
  • Elizabeth F. Krakow, Julie Bergeron, Silvy Lachance, Denis-Claude Roy, and Jean-Sébastien Delisle, “Harnessing the Power of Alloreactivity without Triggering Graft-versus-Host Disease: How Non-engrafting Alloreactive Cellular Therapy Might Change the Landscape of Acute Myeloid Leukemia Treatment,” Blood Reviews, 2014. View at Publisher · View at Google Scholar
  • Alesia Hunt, Dominic Harrington, and Susan Robinson, “Vitamin B-12 deficiency,” Bmj-British Medical Journal, vol. 349, 2014. View at Publisher · View at Google Scholar
  • Steven M. Prideaux, Emma Conway O’Brien, and Timothy J. Chevassut, “The RAG Model: A New Paradigm for Genetic Risk Stratification in Multiple Myeloma,” Bone Marrow Research, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • G Lucarelli, A Isgrò, P Sodani, M Marziali, J Gaziev, K Paciaroni, C Gallucci, L Cardarelli, M Ribersani, C Alfieri, G De Angelis, D Armiento, M Andreani, M Testi, A Amato, O O Akinyanju, and T T Wakama, “Hematopoietic SCT for the Black African and non-Black African variants of sickle cell anemia,” Bone Marrow Transplantation, 2014. View at Publisher · View at Google Scholar
  • I Pal, S Sarkar, S Rajput, K K Dey, S Chakraborty, R Dash, S K Das, D Sarkar, E Barile, S K De, M Pellecchia, P B Fisher, and M Mandal, “BI-69A11 enhances susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt,” British Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  • Yoko Tabe, and Marina Konopleva, “Advances in understanding the leukaemia microenvironment,” British Journal of Haematology, 2014. View at Publisher · View at Google Scholar
  • Almudena de Laiglesia, Ana Lario, Miguel Piris, J. Rafael Cabrera, Rafael Forés, Nieves Dorado, Carlos Vilches, Carmen Regidor, José A. García-Marco, and Rosario de Pablo, “HLA-partially matched cellular therapy (stem-cell microtransplantation) for acute myeloid leukaemia. Description of four cases,” British Journal of Haematology, 2014. View at Publisher · View at Google Scholar
  • Renata Mojzikova, Pavla Koralkova, Dusan Holub, Zuzana Zidova, Dagmar Pospisilova, Jaroslav Cermak, Zuzana Striezencova Laluhova, Karel Indrak, Martina Sukova, Martina Partschova, Jana Kucerova, Monika Horvathova, and Vladimir Divoky, “ Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios ,” British Journal of Haematology, 2014. View at Publisher · View at Google Scholar
  • George A. Follows, Kirit M. Ardeshna, Sally F. Barrington, Dominic J. Culligan, Peter J. Hoskin, David Linch, Shalal Sadullah, Michael V. Williams, and Jennifer Z. Wimperis, “Guidelines for the first line management of classical Hodgkin lymphoma,” British Journal of Haematology, 2014. View at Publisher · View at Google Scholar
  • Sara Raponi, Irene Della Starza, Maria S. De Propris, Ilaria Del Giudice, Francesca R. Mauro, Marilisa Marinelli, Valeria Di Maio, Alfonso Piciocchi, Robin Foà, and Anna Guarini, “Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ-PCR,” British Journal of Haematology, 2014. View at Publisher · View at Google Scholar
  • Evgeny Arons, Sharon Adams, David J. Venzon, Ira Pastan, and Robert J. Kreitman, “Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome,” British Journal of Haematology, 2014. View at Publisher · View at Google Scholar
  • Gro G. Pløen, Line Nederby, Per Guldberg, Maria Hansen, Lene H. Ebbesen, Uffe Birk Jensen, Peter Hokland, and Anni Aggerholm, “ Persistence of DNMT3A mutations at long-term remission in adult patients with AML ,” British Journal of Haematology, 2014. View at Publisher · View at Google Scholar
  • Nada Hamad, David Kliman, O. Giles Best, Melody Caramins, Mark Hertzberg, Robert Lindeman, Ric Porter, and Stephen P. Mulligan, “Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: five cases, a literature review and discussion of management,” British Journal of Haematology, 2014. View at Publisher · View at Google Scholar
  • MinJung Kim, Yee Sun Tan, Wen-Chih Cheng, Tami J. Kingsbury, Shelly Heimfeld, and Curt I. Civin, “ MIR144 and MIR451 regulate human erythropoiesis via RAB14 ,” British Journal of Haematology, 2014. View at Publisher · View at Google Scholar
  • Alessandra Romano, Nunziatina Laura Parrinello, Calogero Vetro, Stefano Forte, Annalisa Chiarenza, Amalia Figuera, Giovanna Motta, Giuseppe Alberto Palumbo, Massimo Ippolito, Ugo Consoli, and Francesco Di Raimondo, “Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy,” British Journal of Haematology, 2014. View at Publisher · View at Google Scholar
  • Marion Strullu, Andre Baruchel, and Helene Cave, “Juvenile myelomonocytic leukemias,” Bulletin Du Cancer, vol. 101, no. 3, pp. 302–313, 2014. View at Publisher · View at Google Scholar
  • Gemma Marcucci, Ari Zimran, Bruno Bembi, John Kanis, Jean-Yves Reginster, Renè Rizzoli, Cyrus Cooper, and Maria Luisa Brandi, “Gaucher Disease and Bone Manifestations,” Calcified Tissue International, 2014. View at Publisher · View at Google Scholar
  • Brian S. White, “Genomic tools in acute myeloid leukemia: From the bench to the bedside,” Cancer, vol. 120, no. 8, pp. 1134–1144, 2014. View at Publisher · View at Google Scholar
  • Masahisa Jinushi, “Immune regulation of therapy-resistant niches: emerging targets for improving anticancer drug responses,” Cancer and Metastasis Reviews, 2014. View at Publisher · View at Google Scholar
  • S. L. Glaser, C. A. Clarke, E. T. Chang, J. Yang, S. L. Gomez, and T. H. Keegan, “Hodgkin lymphoma incidence in California Hispanics: Influence of nativity and tumor Epstein–Barr virus,” Cancer Causes & Control, 2014. View at Publisher · View at Google Scholar
  • Cairong Zhu, Bryan A. Bassig, Kunchong Shi, Peter Boyle, Huan Guo, and Tongzhang Zheng, “Different time trends by gender for the incidence of Hodgkin’s lymphoma among young adults in the USA: a birth cohort phenomenon,” Cancer Causes & Control, 2014. View at Publisher · View at Google Scholar
  • Chang-Chun Niu, Chen Zhao, Zhong Yang, Xiao-Li Zhang, Jing Pan, Chen Zhao, and Wei-Ke Si, “Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway,” Cancer Cell International, vol. 14, no. 1, pp. 74, 2014. View at Publisher · View at Google Scholar
  • Amanda J. Favreau, Calvin P. H. Vary, Peter C. Brooks, and Pradeep Sathyanarayana, “Cryptic collagen IV promotes cell migration and adhesion in myeloid leukemia,” Cancer Medicine, 2014. View at Publisher · View at Google Scholar
  • Bertrand Coiffier, Massimo Federico, Dolores Caballero, Claire Dearden, Franck Morschhauser, Ulrich Jäger, Lorenz Trümper, Emanuele Zucca, Maria Gomes da Silva, Ruth Pettengell, Eckhart Weidmann, Francesco d’Amore, Hervé Tilly, and Pier Luigi Zinzani, “Therapeutic options in relapsed or refractory peripheral T-cell lymphoma,” Cancer Treatment Reviews, 2014. View at Publisher · View at Google Scholar
  • Levent Undar, Sibel Berker Karauzum, Cigdem Aydin, Zafer Cetin, Ozan Salim, and Orhan Kemal Yucel, “Previously Unreported Chromosomal Aberrations of t(3;3)(q29;q23), t(4;11)(q21;q23), and t(11;18)(q10;q10) in a Patient with Accelerated Phase Ph+ CML,” Case Reports in Genetics, vol. 2014, pp. 1–3, 2014. View at Publisher · View at Google Scholar
  • Nicholas Finn, and Jean-Francois Larouche, “Romidepsin Used as Monotherapy in Sequence with Allogeneic Stem Cell Transplant in a Patient with Peripheral T-Cell Lymphoma,” Case Reports in Hematology, vol. 2014, pp. 1–3, 2014. View at Publisher · View at Google Scholar
  • Anthony Mazurek, Youngkyu Park, Cornelius Miething, John E. Wilkinson, Jesse Gillis, Scott W. Lowe, Christopher R. Vakoc, and Bruce Stillman, “Acquired Dependence of Acute Myeloid Leukemia on the DEAD-Box RNA Helicase DDX5,” Cell Reports, 2014. View at Publisher · View at Google Scholar
  • Jung-Yeon Lim, Min-Jung Park, Keon-Il Im, Nayoun Kim, Eun-Joo Jeon, Eun-Jung Kim, Mi-La Cho, and Seok-Goo Cho, “Combination Cell Therapy Using Mesenchymal Stem Cells and Regulatory T-Cells Provides a Synergistic Immunomodulatory Effect Associated With Reciprocal Regulation of Th1/Th2 and Th17/Treg Cells in a Murine Acute Graft-Versus-Host Disease Model,” Cell Transplantation, vol. 23, no. 6, pp. 703–714, 2014. View at Publisher · View at Google Scholar
  • Jonathan Teoh, Sherif Boulos, Joanne Chieng, Neville W. Knuckey, and Bruno P. Meloni, “Erythropoietin Increases Neuronal NDPKA Expression, and NDPKA Up-Regulation as well as Exogenous Application Protects Cortical Neurons from In Vitro Ischemia-Related Insults,” Cellular and Molecular Neurobiology, 2014. View at Publisher · View at Google Scholar
  • Minna Cao, Dongshuang Wu, and Rong Cao, “Recent Advances in the Stabilization of Platinum Electrocatalysts for Fuel-Cell Reactions,” Chemcatchem, vol. 6, no. 1, pp. 26–45, 2014. View at Publisher · View at Google Scholar
  • Jing-bo Zeng, Yun Zhang, Qi Sun, and Yu-xiu Li, “Phosphatase and Tension Homolog Overexpression in Insulin Resistant Diabetic Adipose Tissue,” Chinese Medical Sciences Journal, vol. 29, no. 3, pp. 167–173, 2014. View at Publisher · View at Google Scholar
  • Adili Reheman, Xiaohong Xu, Emily C. Reddy, and Heyu Ni, “Targeting Activated Platelets and Fibrinolysis Hitting Two Birds with One Stone,” Circulation Research, vol. 114, no. 7, pp. 1070–1073, 2014. View at Publisher · View at Google Scholar
  • Sonia L. La'ulu, Joely A. Straseski, Robert L. Schmidt, and Jonathan R. Genzen, “Thrombin-mediated degradation of parathyroid hormone in serum tubes,” Clinica Chimica Acta, 2014. View at Publisher · View at Google Scholar
  • Rebecca S. Y. Wong, and Soon-Keng Cheong, “Role of mesenchymal stem cells in leukaemia: Dr. Jekyll or Mr. Hyde?,” Clinical and Experimental Medicine, vol. 14, no. 3, pp. 235–248, 2014. View at Publisher · View at Google Scholar
  • Sarah Alexandra van Blydenstein, Moosa Patel, Vinitha Philip, Atul Lakha, Sugeshnee Pather, Tracy Westgarth-Taylor, Eddison Thompson, and Avinash Kolloori, “Classical Hodgkin Lymphoma involving the central nervous system (brain) - an unusual presentation,” Clinical Case Reports, 2014. View at Publisher · View at Google Scholar
  • Olli Ruuskanen, and Asko Jarvinen, “What is the Real Role of Respiratory Viruses in Severe Community-Acquired Pneumonia?,” Clinical Infectious Diseases, vol. 59, no. 1, pp. 71–73, 2014. View at Publisher · View at Google Scholar
  • Jason R. Westin, “Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma,” Clinical Lymphoma Myeloma and Leukemia, vol. 14, no. 5, pp. 335–342, 2014. View at Publisher · View at Google Scholar
  • Gayatri Vaidyanathan, and Myron S. Czuczman, “Follicular Lymphoma Grade 3: Review and Updates,” Clinical Lymphoma Myeloma and Leukemia, 2014. View at Publisher · View at Google Scholar
  • Maria Gkotzamanidou, Evangelos Terpos, Efstathios Kastritis, and Meletios Athanasios Dimopoulos, “Hematologic response and stabilization of renal function in a patient with LCDD after Lenalidomide treatment: A novel therapeutic approach?,” Clinical Lymphoma Myeloma and Leukemia, 2014. View at Publisher · View at Google Scholar
  • Annalise E. Zemlin, Rajiv T. Erasmus, and Richard H. Glashoff, “Role of inflammation in HIV-1 disease progression and prognosis,” Critical Reviews in Clinical Laboratory Sciences, vol. 51, no. 2, pp. 98–111, 2014. View at Publisher · View at Google Scholar
  • Semra Paydas, “Hepatitis C virus and lymphoma,” Critical Reviews in Oncology/Hematology, 2014. View at Publisher · View at Google Scholar
  • James Aries, and Silvia Montoto, “Managing HIV and Hodgkin Lymphoma in the Twenty-first century,” Current Hematologic Malignancy Reports, 2014. View at Publisher · View at Google Scholar
  • Angela C. Weyand, and Jordan A. Shavit, “Zebrafish as a model system for the study of hemostasis and thrombosis,” Current Opinion in Hematology, vol. 21, no. 5, pp. 418–422, 2014. View at Publisher · View at Google Scholar
  • Martin J. Hoogduijn, Michiel G. H. Betjes, and Carla C. Baan, “Mesenchymal stromal cells for organ transplantation: different sources and unique characteristics?,” Current Opinion in Organ Transplantation, vol. 19, no. 1, pp. 41–46, 2014. View at Publisher · View at Google Scholar
  • Barbara Squiban, and J. Kimble Frazer, “Danio rerio: Small Fish Making a Big Splash in Leukemia,” Current Pathobiology Reports, 2014. View at Publisher · View at Google Scholar